BACKGROUND Different parts of the plant Mikania micrantha are traditionally used to treat several diseases like dysentery, body sprain, diabetes, snake bites, itches, gout, flatulence, rheumatism and cancer. Therefore, the present study was undertaken to evaluate the antiinflammatory activity of the Ethanolic Extracts of leaves of Mikania micrantha (EEMM) on carrageenan-induced rat paw oedema, granuloma-pouch method and adjuvant-induced chronic arthritis on experimental animals.
Mikania micrantha is an extremely fast growing perennial creeping weed. Its native distribution is in Central and South America. (2) Different parts of the plant Mikania micrantha are used to treat fever, jaundice, dysentery, rheumatism, colds, respiratory diseases and scorpion stings. (3) The leaves have been reported as good haemostatic agents. (4) In India, the plant is used by different ethnic communities for treatment of dysentery, body sprain, diabetes, snake bites, itches, gout, flatulence, rheumatism and cancer. (5) The plant is enriched with several sesquiterpene lactones and phenolic compounds. Active constituents isolated from the plant are the alkaloids, sterols, diterpenes, polyphenols, flavonoids, sesquiterpene lactones, etc. The most common phytosterols detected in aerial parts of this plant are stigmasterol, luperol and sitosterol. (6) Terpenoids like amyrin and friedelin are abundant in Mikania micrantha. Traditionally, the decoction of leaves has been used to treat painful conditions. (7) 
MATERIALS AND METHODS Plant Material
The study was carried out in the Department of Pharmacology. Fresh matured leaves of Mikania micrantha were collected from the campus of Assam Medical College, Dibrugarh, Assam. The plants were authenticated by Prof. M.
Islam, Department of Life Sciences, Dibrugarh University, Assam.
Plant Extract
Fresh leaves of 3 kg of Mikania micrantha were air dried at room temperature, powdered by grinder and soaked in 95% alcohol, allowed to stand for 6 hours in an air tight container. After 24 hours of maceration, slow percolation was done and then the extracts were prepared by evaporation in a rotary evaporator under controlled temperature and reduced pressure. When completely dry the extract was scraped out, weighed and stored. (8) 
Animals
All the animals used in the study were procured from Central Animal House, Assam Medical College and Hospital, Dibrugarh, Assam, during the months of December and January 2009. Duration of my study was 2 months. The study was conducted in accordance with CPCSEA (Committee for the Purpose of Control and Supervision of Experiment on Animals) guidelines and the study was approved by the Institutional Animal Ethical Committee (Registration No. -634/02/a/CPCSEA). They were fed with standard diet and water ad libitum was provided. Experimental animals used were healthy albino rats of the species Rattus norvegicus of either sex weighing 150 -200 gm. Minimum numbers of animals (at least 5) were used in this study for achieving the hypothesis or to find a significant difference between the compared groups through a statistical analysis. (9) Acute Toxicity Study Acute toxicity test was done for the ethanolic extract of Mikania micrantha following OECD 423 guidelines. (10) An arbitrary dose of 500 mg/kg was selected for the study, as the extract was found safe even at doses more than 2000 mg/kg without any sign of toxicity or mortality. All the drugs were administered orally and the volume of medicaments kept constant at 10 mL/kg body weight of the animals.
Anti-inflammatory Studies for each Experiment, the Animals were divided into 4 Groups with 6 Animals in each Group

(a) Anti-Inflammatory Study against Acute Inflammation
The anti-inflammatory activity of EEMM against acute inflammation was tested by carrageenan-induced rat paw oedema method. Acute inflammation was produced by subplantar injection of 0.1 mL of freshly prepared 1% carrageenan suspension in normal saline in the right hind paw of rats in each group. The animals were treated with 3% gum acacia, EEMM or aspirin in the respective groups, 1 h before carrageenan injection. The paw volume was measured plethysmometrically as described by Chattopadhyay et al at "0" h and then at 1 st , 2 nd , 3 rd and 4 th after carrageenan injection. (11) Increase in paw oedema was measured as the difference between the paw volume at "0" h and paw volume at the end of each hour. The drugs were administered orally in the respective groups one hour before carrageenan injection. The percentage inhibition of the rat paw oedema was calculated after each hour of carrageenan injection up to 4 hours by the formula. (12) 
Control mean
The data were statistically analysed using One-Way ANOVA followed by Dunnett's multiple comparison test and "P" values less than 0.05 were considered significant.
(b) Anti-Inflammatory Study against Sub-Acute Inflammation
The anti-inflammatory activity of EEMM leaves against subacute inflammation was tested by Granuloma pouch method. Rats were anaesthetised with ether and subcutaneous dorsal air pouches were then prepared at the backs by injecting 20 mL of air with the help of a fine needle after proper shaving and disinfection. Then 1 mL of 20% carrageenan suspension in sesame oil was injected into each pouch; 48 h later air was withdrawn from the pouch and 72 h later any resulting adhesions were broken.
The animals were treated with 3% gum acacia, EEMM or aspirin in the respective groups for 4 days starting from the day of pouch formation. On the 5th day, the animals were sacrificed under ether anaesthesia. The pouch was opened and exudates were sucked out and the amount measured in glass cylinders. The average values of the exudates of the control and the test groups were calculated. The percentage inhibition was then calculated for all the groups. (13) 
c) Anti-Inflammatory Study against Chronic Inflammation
The anti-inflammatory activity of EEMM against chronic inflammation was tested by Freund's adjuvant-induced arthritis method in rats. On Day 1, the animals were injected into the subplantar region of the left hind paw with 0.1 mL of complete Freund's adjuvant. Dosing with the test compounds or the standards to the respective groups was started on the same day and continued for 12 days. The paw volumes of both sides and the body weights were recorded on the day of injection.
The paw volumes were measured plethysmographically as in the paw oedema test. On Day 5 and for the secondary lesions, the volume of the injected paw was measured again indicating the primary lesion and the influence of the therapeutic agent on this phase. The severity of the disease was followed by measurement of the noninjected paw (Secondary lesions) with a plethysmometer. Purposely, from Day 13 to 21, the animals were not administered with the test compound or the standard. The non-injected paw volume and the body weight were measured on 21 st day [12] and the polyarthritis severity score was graded on 0 to 4: 0= No swelling; 1= Phalanx joint involvement; 2= Phalanx joint and all digits involvement; 3= Whole region of the ankle involvement; 4= Paw and ankle involvement. The joint score was 12 maximum including 3 secondary arthritis paws for each rat. (14) 1. For primary lesions: The % inhibition of paw volume of the injected right paw over control was measured at the 5 th day of experiment.
For secondary lesions: The % inhibition of paw volume
of non-injected left paw over control was measured at the 21 st day of experiment.
An Arthritis Index was calculated as the sum of the scores as indicated above for each animal.
Statistical analysis was done using One-Way ANOVA followed by Dunnett's Multiple Comparison test. Significance level of < 0.05 was considered as significant. (15) 
RESULTS
In acute oral toxicity tests, the LD50 of EEMM was found to be more than 2000 mg/kg. 
Group
DISCUSSION
Our study showed that ethanolic extracts of the leaves of Mikania micrantha produced significant acute and sub-acute anti-inflammatory activity against carrageenan-induced acute inflammation and at the 4 th h the effect of EEMM at the dose of 200 mg/kg showed almost similar to the aspirin at the dose of 100 mg/kg when given orally.
In Granuloma pouch method, ethanolic extracts of EEMM leaves showed highly significant anti-inflammatory activity against sub-acute inflammation. The effect of EEMM at the dose of 400 mg/kg was almost similar to that of aspirin 100 mg/kg. In Freund's complete adjuvant-induced arthritis model, EEMM at the dose of 200 mg/kg and 400 mg/kg showed no significant reduction of paw oedema formation.
EEMM at the doses [200 mg/kg and 400 mg/kg] showed no significant reduction of the arthritis index and significantly reduced the decrease in weight in the adjuvant arthritis rats as compared to the control group as on 21st day of adjuvant injection. Ulcers produced by aspirin may have impact on food and possibly water intake leading to increased weight loss in the standard group.
However, a decreased appetite could also contribute to the weight loss observed since this phenomenon is an established feature of the active immune phase arthritis in humans. (16) Adjuvant arthritis is characterised by weight loss (17) and body weight loss is associated with increased production of pro-inflammatory cytokines such as TNF-α (P < 0.001) and interleukin-1.
CONCLUSION
The data obtained from different groups were compared for statistical significance by using One-Way ANOVA followed by Dunnett's 't' test. All the findings suggest that ethanolic extract of Mikania micrantha leaves possess significant antiinflammatory activity against acute and sub-acute inflammation, but there is no significance against chronic inflammation in various experimental animal models.
